The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10170, p. 396
The League of Nations Health Organization, the predecessor of WHO, was given the task of monitoring influenza outbreaks, and in the UK the new Ministry of...
Medical research | Antigens | Global health | Antiviral agents | Pandemics | Poultry | Severe acute respiratory syndrome | Outbreaks | Vaccines | Avian flu | Acquired immune deficiency syndrome--AIDS | Influenza | Human immunodeficiency virus--HIV | Chickens | Anxiety | Respiration
Medical research | Antigens | Global health | Antiviral agents | Pandemics | Poultry | Severe acute respiratory syndrome | Outbreaks | Vaccines | Avian flu | Acquired immune deficiency syndrome--AIDS | Influenza | Human immunodeficiency virus--HIV | Chickens | Anxiety | Respiration
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2013, Volume 208, Issue 8, pp. 1305 - 1314
Background. The 2010-2011 influenza season was dominated by influenza A(H3N2) virus, but influenza A(H1N1) pdmO9 (pH1N1) and B viruses cocirculated. This...
Medical conditions | Nervous system diseases | Influenza | Lung diseases | Antivirals | Viral diseases | Viruses | Adults | Children | H3N2 subtype influenza A virus | influenza | influenza hospitalizations | influenza surveillance | severe influenza | influenza A(H1N1) pdm09 | PANDEMIC-UNITED-STATES | INFECTIOUS DISEASES | A H1N1 | VACCINE | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | ANTIVIRAL TREATMENT | INFECTION | OUTCOMES | United States - epidemiology | Influenza A Virus, H1N1 Subtype - classification | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Orthomyxoviridae - classification | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Public Health Surveillance | Influenza, Human - mortality | Adult | Female | Influenza, Human - virology | Influenza, Human - therapy | Odds Ratio | Child | Influenza B virus - classification | Influenza A Virus, H3N2 Subtype - classification | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Respiration, Artificial | Adolescent | Critical Care | Aged | Orthomyxoviridae - isolation & purification | Influenza viruses | Development and progression | Research | Demographic aspects | Identification and classification
Medical conditions | Nervous system diseases | Influenza | Lung diseases | Antivirals | Viral diseases | Viruses | Adults | Children | H3N2 subtype influenza A virus | influenza | influenza hospitalizations | influenza surveillance | severe influenza | influenza A(H1N1) pdm09 | PANDEMIC-UNITED-STATES | INFECTIOUS DISEASES | A H1N1 | VACCINE | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | ANTIVIRAL TREATMENT | INFECTION | OUTCOMES | United States - epidemiology | Influenza A Virus, H1N1 Subtype - classification | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Orthomyxoviridae - classification | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Public Health Surveillance | Influenza, Human - mortality | Adult | Female | Influenza, Human - virology | Influenza, Human - therapy | Odds Ratio | Child | Influenza B virus - classification | Influenza A Virus, H3N2 Subtype - classification | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Respiration, Artificial | Adolescent | Critical Care | Aged | Orthomyxoviridae - isolation & purification | Influenza viruses | Development and progression | Research | Demographic aspects | Identification and classification
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 8, pp. 1200 - 1208
Background. Some studies suggest that influenza vaccination might be protective against severe influenza outcomes in vaccinated persons who become infected. We...
influenza | influenza vaccine | severe illness | adults | INFECTIOUS DISEASES | RISK | MICROBIOLOGY | DIAGNOSTIC-TESTS | IMMUNOLOGY | PROPENSITY SCORES | OSELTAMIVIR | DISEASE | MORTALITY BENEFITS | OUTCOMES | LABORATORY-CONFIRMED INFLUENZA | RESPIRATORY SYNCYTIAL VIRUS | CHARLSON COMORBIDITY INDEX | Severity of Illness Index | Intensive Care Units | United States | Humans | Middle Aged | Vaccination | Logistic Models | Male | Hospitalization | Influenza Vaccines - immunology | Pneumonia - diagnosis | Influenza, Human - mortality | Female | Aged | Seasons | Influenza, Human - prevention & control | Influenza, Human - immunology | Influenza vaccines | Care and treatment | Dosage and administration | Adults | Health aspects | Influenza | Major and Brief Reports
influenza | influenza vaccine | severe illness | adults | INFECTIOUS DISEASES | RISK | MICROBIOLOGY | DIAGNOSTIC-TESTS | IMMUNOLOGY | PROPENSITY SCORES | OSELTAMIVIR | DISEASE | MORTALITY BENEFITS | OUTCOMES | LABORATORY-CONFIRMED INFLUENZA | RESPIRATORY SYNCYTIAL VIRUS | CHARLSON COMORBIDITY INDEX | Severity of Illness Index | Intensive Care Units | United States | Humans | Middle Aged | Vaccination | Logistic Models | Male | Hospitalization | Influenza Vaccines - immunology | Pneumonia - diagnosis | Influenza, Human - mortality | Female | Aged | Seasons | Influenza, Human - prevention & control | Influenza, Human - immunology | Influenza vaccines | Care and treatment | Dosage and administration | Adults | Health aspects | Influenza | Major and Brief Reports
Journal Article
2010, McGill-Queen's/Associated Medical Services Studies in the History of Medicine, Health, and Society, ISBN 9780773536180, Volume 76, xii, 451
Will SARS or another pandemic influenza reoccur and, if it does, have we learned how to manage pandemics more effectively? In SARS Unmasked risk communication...
SARS (Disease) - Ontario - Toronto | SARS (Disease) - Risk factors - Canada | Canada | Severe Acute Respiratory Syndrome - epidemiology - Canada | Risk Factors - Canada | Severe Acute Respiratory Syndrome - prevention & control - Canada | Health | Communicable diseases - Risk factors - Canada | Disease Notification - methods - Canada | Health risk communication - Canada | Information Dissemination - Canada | Disease Outbreaks - prevention & control - Canada | Communicable diseases | SARS (Disease) | Anthropology | Ontario | Risk factors | Toronto | Health risk communication | Severe Acute Respiratory Syndrome | epidemiology | Disease Notification | methods | prevention & control
SARS (Disease) - Ontario - Toronto | SARS (Disease) - Risk factors - Canada | Canada | Severe Acute Respiratory Syndrome - epidemiology - Canada | Risk Factors - Canada | Severe Acute Respiratory Syndrome - prevention & control - Canada | Health | Communicable diseases - Risk factors - Canada | Disease Notification - methods - Canada | Health risk communication - Canada | Information Dissemination - Canada | Disease Outbreaks - prevention & control - Canada | Communicable diseases | SARS (Disease) | Anthropology | Ontario | Risk factors | Toronto | Health risk communication | Severe Acute Respiratory Syndrome | epidemiology | Disease Notification | methods | prevention & control
Book
Emerging Infectious Diseases, ISSN 1080-6040, 01/2006, Volume 12, Issue 1, pp. 73 - 77
The threat of a human influenza pandemic has greatly increased over the past several years with the emergence of highly virulent avian influenza viruses,...
A VIRUS | INFECTIOUS DISEASES | TRANSMISSION | H9N2 | AVIAN INFLUENZA | VACCINE | SARS | INFECTION | LESSONS | IMMUNOLOGY | OUTBREAK | H5N1 INFLUENZA | United States - epidemiology | Severe Acute Respiratory Syndrome - epidemiology | Humans | Influenza, Human - epidemiology | Severe Acute Respiratory Syndrome - prevention & control | Animals | Influenza Vaccines - immunology | Influenza Vaccines - biosynthesis | Disaster Planning - trends | Disease Outbreaks - prevention & control | Influenza, Human - virology | Influenza, Human - prevention & control | Influenza, Human - immunology | Emergency management | Development and progression | Control | Influenza | influenza | Pandemic | vaccine | countermeasure | antiviral | avian
A VIRUS | INFECTIOUS DISEASES | TRANSMISSION | H9N2 | AVIAN INFLUENZA | VACCINE | SARS | INFECTION | LESSONS | IMMUNOLOGY | OUTBREAK | H5N1 INFLUENZA | United States - epidemiology | Severe Acute Respiratory Syndrome - epidemiology | Humans | Influenza, Human - epidemiology | Severe Acute Respiratory Syndrome - prevention & control | Animals | Influenza Vaccines - immunology | Influenza Vaccines - biosynthesis | Disaster Planning - trends | Disease Outbreaks - prevention & control | Influenza, Human - virology | Influenza, Human - prevention & control | Influenza, Human - immunology | Emergency management | Development and progression | Control | Influenza | influenza | Pandemic | vaccine | countermeasure | antiviral | avian
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 363, Issue 9404, pp. 234 - 236
Live-animal markets (wet markets) provide a source of vertebrate and invertebrate animals for customers in tropical and subtropical regions of the world. Wet...
MEDICINE, GENERAL & INTERNAL | SARS VIRUS | TRANSMISSION | AREA | GENE | AVIAN INFLUENZA | A VIRUSES | LIVE-BIRD MARKETS | HONG-KONG | QUAIL | Food Industry - methods | Severe Acute Respiratory Syndrome - epidemiology | Poultry | Humans | Severe Acute Respiratory Syndrome - transmission | Severe Acute Respiratory Syndrome - veterinary | Influenza, Human - epidemiology | Communicable Diseases, Emerging - epidemiology | Disease Outbreaks - statistics & numerical data | Influenza A virus - isolation & purification | Influenza, Human - transmission | Communicable Diseases, Emerging - veterinary | Zoonoses | Disease Reservoirs - veterinary | Animals | Hong Kong - epidemiology | Poultry Diseases - transmission | Communicable Diseases, Emerging - transmission | Disease Vectors | Poultry Diseases - epidemiology | Avian influenza | Research | Foodborne diseases | Communicable diseases | Severe acute respiratory syndrome | Risk factors | Viruses | Influenza | Public health
MEDICINE, GENERAL & INTERNAL | SARS VIRUS | TRANSMISSION | AREA | GENE | AVIAN INFLUENZA | A VIRUSES | LIVE-BIRD MARKETS | HONG-KONG | QUAIL | Food Industry - methods | Severe Acute Respiratory Syndrome - epidemiology | Poultry | Humans | Severe Acute Respiratory Syndrome - transmission | Severe Acute Respiratory Syndrome - veterinary | Influenza, Human - epidemiology | Communicable Diseases, Emerging - epidemiology | Disease Outbreaks - statistics & numerical data | Influenza A virus - isolation & purification | Influenza, Human - transmission | Communicable Diseases, Emerging - veterinary | Zoonoses | Disease Reservoirs - veterinary | Animals | Hong Kong - epidemiology | Poultry Diseases - transmission | Communicable Diseases, Emerging - transmission | Disease Vectors | Poultry Diseases - epidemiology | Avian influenza | Research | Foodborne diseases | Communicable diseases | Severe acute respiratory syndrome | Risk factors | Viruses | Influenza | Public health
Journal Article
Brazilian Journal of Infectious Diseases, ISSN 1413-8670, 09/2018, Volume 22, Issue 5, pp. 377 - 386
Influenza continues to drive seasonal morbidity, particularly in settings with low vaccine coverage. To describe the influenza cases and viral circulation...
SARI | B/Victoria | Subtype | Influenza | A/H3 | ILI | INFECTIOUS DISEASES | VACCINE | VIRUSES | Severe Acute Respiratory Syndrome - epidemiology | Age Distribution | Influenza, Human - pathology | Prospective Studies | Romania - epidemiology | Severe Acute Respiratory Syndrome - virology | Humans | Mass Vaccination - statistics & numerical data | Middle Aged | Child, Preschool | Infant | Male | Tertiary Care Centers - statistics & numerical data | Young Adult | Time Factors | Adult | Female | Influenza, Human - virology | Seasons | Child | Comorbidity | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Influenza A virus - isolation & purification | Epidemiological Monitoring | Adolescent | Aged | Severe Acute Respiratory Syndrome - pathology | Population Surveillance | Influenza vaccines | Surveys | Analysis | Elementary school students | Sentinel health events | Health aspects | Influenza research
SARI | B/Victoria | Subtype | Influenza | A/H3 | ILI | INFECTIOUS DISEASES | VACCINE | VIRUSES | Severe Acute Respiratory Syndrome - epidemiology | Age Distribution | Influenza, Human - pathology | Prospective Studies | Romania - epidemiology | Severe Acute Respiratory Syndrome - virology | Humans | Mass Vaccination - statistics & numerical data | Middle Aged | Child, Preschool | Infant | Male | Tertiary Care Centers - statistics & numerical data | Young Adult | Time Factors | Adult | Female | Influenza, Human - virology | Seasons | Child | Comorbidity | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Influenza A virus - isolation & purification | Epidemiological Monitoring | Adolescent | Aged | Severe Acute Respiratory Syndrome - pathology | Population Surveillance | Influenza vaccines | Surveys | Analysis | Elementary school students | Sentinel health events | Health aspects | Influenza research
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2015, Volume 75, pp. 21 - 26
Highlights • Detection rate attributable to illness reflects a more accurate description of the prevalence of viruses causing respiratory disease. • Influenza,...
Infectious Disease | Allergy and Immunology | Pneumonia | Severe acute respiratory illness | HIV | Respiratory virus infection | Controls | South Africa | Influenza like illness | Disease association | MORTALITY | ETIOLOGY | COMMUNITY-ACQUIRED PNEUMONIA | CHILDREN | RHINOVIRUS INFECTIONS | VIROLOGY | REQUIRING HOSPITALIZATION | VIRAL CULTURE | REVERSE TRANSCRIPTION-PCR | SYNCYTIAL VIRUS | EPIDEMIOLOGY | HIV Infections - blood | Severe Acute Respiratory Syndrome - epidemiology | Adenoviridae | Prevalence | HIV Seropositivity | Severe Acute Respiratory Syndrome - virology | Humans | Influenza, Human - blood | Orthomyxoviridae | Respirovirus | Severe Acute Respiratory Syndrome - etiology | HIV Infections - complications | Influenza, Human - virology | Rhinovirus | Prevention | Adenoviruses | Influenza | Lung diseases | Meningitis | HIV (Viruses) | Health aspects | Prevalence studies (Epidemiology) | Influenza viruses | Medical research | Medicine, Experimental
Infectious Disease | Allergy and Immunology | Pneumonia | Severe acute respiratory illness | HIV | Respiratory virus infection | Controls | South Africa | Influenza like illness | Disease association | MORTALITY | ETIOLOGY | COMMUNITY-ACQUIRED PNEUMONIA | CHILDREN | RHINOVIRUS INFECTIONS | VIROLOGY | REQUIRING HOSPITALIZATION | VIRAL CULTURE | REVERSE TRANSCRIPTION-PCR | SYNCYTIAL VIRUS | EPIDEMIOLOGY | HIV Infections - blood | Severe Acute Respiratory Syndrome - epidemiology | Adenoviridae | Prevalence | HIV Seropositivity | Severe Acute Respiratory Syndrome - virology | Humans | Influenza, Human - blood | Orthomyxoviridae | Respirovirus | Severe Acute Respiratory Syndrome - etiology | HIV Infections - complications | Influenza, Human - virology | Rhinovirus | Prevention | Adenoviruses | Influenza | Lung diseases | Meningitis | HIV (Viruses) | Health aspects | Prevalence studies (Epidemiology) | Influenza viruses | Medical research | Medicine, Experimental
Journal Article
JAMA: The Journal of the American Medical Association, ISSN 0098-7484, 11/2009, Volume 302, Issue 17, pp. 1880 - 1887
CONTEXT In March 2009, novel 2009 influenza A(H1N1) was first reported in the southwestern United States and Mexico. The population and health care system in...
MORTALITY | H5N1 | MEDICINE, GENERAL & INTERNAL | DISEASE | Age Distribution | Multiple Organ Failure - mortality | Humans | Middle Aged | Critical Illness | Male | Influenza, Human - complications | Respiratory Distress Syndrome, Adult - mortality | Respiratory Distress Syndrome, Adult - etiology | Young Adult | Aged, 80 and over | Influenza A Virus, H1N1 Subtype | Influenza, Human - mortality | Adult | Female | Influenza, Human - diagnosis | Retrospective Studies | Influenza, Human - therapy | Child | Antiviral Agents - therapeutic use | Mexico - epidemiology | Kaplan-Meier Estimate | Hospitalization | Respiration, Artificial | Multiple Organ Failure - etiology | Adolescent | Hypoxia | Neuraminidase - antagonists & inhibitors | Aged | APACHE | Care and treatment | Young adults | Critically ill | Severe acute respiratory syndrome | Patient outcomes | Swine influenza | Diagnosis | Health aspects | Hospitals | Swine flu | Medical treatment | Clinical outcomes
MORTALITY | H5N1 | MEDICINE, GENERAL & INTERNAL | DISEASE | Age Distribution | Multiple Organ Failure - mortality | Humans | Middle Aged | Critical Illness | Male | Influenza, Human - complications | Respiratory Distress Syndrome, Adult - mortality | Respiratory Distress Syndrome, Adult - etiology | Young Adult | Aged, 80 and over | Influenza A Virus, H1N1 Subtype | Influenza, Human - mortality | Adult | Female | Influenza, Human - diagnosis | Retrospective Studies | Influenza, Human - therapy | Child | Antiviral Agents - therapeutic use | Mexico - epidemiology | Kaplan-Meier Estimate | Hospitalization | Respiration, Artificial | Multiple Organ Failure - etiology | Adolescent | Hypoxia | Neuraminidase - antagonists & inhibitors | Aged | APACHE | Care and treatment | Young adults | Critically ill | Severe acute respiratory syndrome | Patient outcomes | Swine influenza | Diagnosis | Health aspects | Hospitals | Swine flu | Medical treatment | Clinical outcomes
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 08/2019, Volume 38, Issue 8, pp. 866 - 872
BACKGROUND:In an exploratory analysis of an inactivated quadrivalent influenza vaccine (IIV4) trial in children 6–35 months without risk factors for influenza,...
influenza | DIAGNOSIS | INFECTIOUS DISEASES | VACCINE | quadrivalent influenza vaccine | MODERATE-TO-SEVERE | ILLNESS | IMMUNOLOGY | HOSPITALIZATION | symptoms | OUTPATIENT | healthcare utilization | DISEASE BURDEN | PEDIATRICS | OUTCOMES | YOUNG-CHILDREN | SEVERITY | Influenza vaccines | Care and treatment | Usage | Analysis | Influenza | Clinical trials | Pediatric research | Risk factors
influenza | DIAGNOSIS | INFECTIOUS DISEASES | VACCINE | quadrivalent influenza vaccine | MODERATE-TO-SEVERE | ILLNESS | IMMUNOLOGY | HOSPITALIZATION | symptoms | OUTPATIENT | healthcare utilization | DISEASE BURDEN | PEDIATRICS | OUTCOMES | YOUNG-CHILDREN | SEVERITY | Influenza vaccines | Care and treatment | Usage | Analysis | Influenza | Clinical trials | Pediatric research | Risk factors
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2017, Volume 17, Issue 1, pp. 745 - 8
Background: Over the last decade, capacity for influenza surveillance and research in West Africa has strengthened. Data from these surveillance systems showed...
Epidemiology | Influenza | West Africa | SOUTH-AFRICA | INFECTIOUS DISEASES | INFECTIONS | SENTINEL SURVEILLANCE | Severe Acute Respiratory Syndrome - epidemiology | Severe Acute Respiratory Syndrome - virology | Humans | Influenza A Virus, H3N2 Subtype - pathogenicity | Middle Aged | Child, Preschool | Infant | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza, Human - epidemiology | Male | Africa, Western - epidemiology | Young Adult | Adolescent | Adult | Female | Influenza, Human - virology | Aged | Seasons | Child | Influenza viruses | Research
Epidemiology | Influenza | West Africa | SOUTH-AFRICA | INFECTIOUS DISEASES | INFECTIONS | SENTINEL SURVEILLANCE | Severe Acute Respiratory Syndrome - epidemiology | Severe Acute Respiratory Syndrome - virology | Humans | Influenza A Virus, H3N2 Subtype - pathogenicity | Middle Aged | Child, Preschool | Infant | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza, Human - epidemiology | Male | Africa, Western - epidemiology | Young Adult | Adolescent | Adult | Female | Influenza, Human - virology | Aged | Seasons | Child | Influenza viruses | Research
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 7/2013, Volume 57, Issue 2, pp. 167 - 175
Background. In most seasons, the influenza vaccine is effective in preventing influenza, but it is not clear whether it is equally effective in preventing mild...
Influenza vaccines | Nervous system diseases | Pandemics | Influenza | Vaccination | Predisposing factors | Chronic diseases | Hospital admissions | Hospitalization | ARTICLES AND COMMENTARIES | Cardiovascular diseases | vaccine effectiveness | influenza virus | influenza vaccine | severe influenza | UNITED-STATES | CHILDREN 6 | INFECTIOUS DISEASES | AUSTRALIA | PANDEMIC INFLUENZA | MICROBIOLOGY | IMMUNOLOGY | SEASONS | MONOVALENT | HOSPITALIZATIONS | MORTALITY BENEFITS | EPIDEMICS | AGE | Community-Acquired Infections - diagnosis | Influenza Vaccines - administration & dosage | Influenza, Human - pathology | Prognosis | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Case-Control Studies | Young Adult | Inpatients | Cross Infection - pathology | Aged, 80 and over | Adult | Female | Influenza, Human - diagnosis | Child | Infant, Newborn | Cross Infection - epidemiology | Cross Infection - prevention & control | Influenza, Human - epidemiology | Pregnancy | Influenza Vaccines - immunology | Outpatients | Community-Acquired Infections - pathology | Spain - epidemiology | Adolescent | Cross Infection - diagnosis | Aged | Community-Acquired Infections - prevention & control | Influenza, Human - prevention & control | Prevention | Usage | Health aspects
Influenza vaccines | Nervous system diseases | Pandemics | Influenza | Vaccination | Predisposing factors | Chronic diseases | Hospital admissions | Hospitalization | ARTICLES AND COMMENTARIES | Cardiovascular diseases | vaccine effectiveness | influenza virus | influenza vaccine | severe influenza | UNITED-STATES | CHILDREN 6 | INFECTIOUS DISEASES | AUSTRALIA | PANDEMIC INFLUENZA | MICROBIOLOGY | IMMUNOLOGY | SEASONS | MONOVALENT | HOSPITALIZATIONS | MORTALITY BENEFITS | EPIDEMICS | AGE | Community-Acquired Infections - diagnosis | Influenza Vaccines - administration & dosage | Influenza, Human - pathology | Prognosis | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Case-Control Studies | Young Adult | Inpatients | Cross Infection - pathology | Aged, 80 and over | Adult | Female | Influenza, Human - diagnosis | Child | Infant, Newborn | Cross Infection - epidemiology | Cross Infection - prevention & control | Influenza, Human - epidemiology | Pregnancy | Influenza Vaccines - immunology | Outpatients | Community-Acquired Infections - pathology | Spain - epidemiology | Adolescent | Cross Infection - diagnosis | Aged | Community-Acquired Infections - prevention & control | Influenza, Human - prevention & control | Prevention | Usage | Health aspects
Journal Article